Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein

Background: Head and neck squamous cell carcinoma (HNSCC) is one most prevalent cancers among worldwide. Aim of this study was to evaluate possible effect of bevacizumab, a vascular endothelial growth (VEGF) factor monoclonal antibody on HNSCC cells in vitro to evaluate angiogenic profile changes. M...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Hematol Oncol Stem Cell Res
Hlavní autoři: Heydar, Hossein, Mansouri, Kamran, Norooznezhad, Maryam, Norooznezhad, Fatemeh, Mohamadnia, Abdolreza, Bahrami, Naghmeh
Médium: Artigo
Jazyk:Inglês
Vydáno: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6141426/
https://ncbi.nlm.nih.gov/pubmed/30233776
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky